Anti-diabetic potential of ‘Safūf-i-Dhayābītus’ as standalone and as an adjuvant with glibenclamide in streptozotocin-induced diabetic rats

Presently, Diabetes mellitus (DM) is categorized as an epidemic disease due to its high prevalence of mortality rate and morbidity, and is also considered as the main threat to the global population. Synthetic drugs used alone for the treatment of DM cause serious adverse effects and insufficiently...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Phytomedicine Plus : International journal of phytotherapy and phytopharmacology Ročník 2; číslo 1; s. 100218
Hlavní autoři:	Nasir, Abu, Ansari, Athar Parvez, Rafeeqi, Towseef Amin, Goswami, Pankaj, Wadud, Abdul, Akbar, Seema, Ansari, Huzaifa
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	Elsevier B.V 01.02.2022 Elsevier
Témata:	Adjuvant therapy adjuvants albino Antidiabetic blood serum cholesterol creatinine Diabetes mellitus disease control Glibenclamide glycemic effect histopathology kidneys liver morbidity mortality nephroprotective effect Safūf-i-Dhayābītus streptozotocin triacylglycerols Unani medicine urea Glibenclamide Unani medicine Diabetes mellitus Antidiabetic Adjuvant therapy Safūf-i-Dhayābītus
ISSN:	2667-0313, 2667-0313
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!